Total Payments
$798,138
2024 Payments
$223,891
Companies
54
Transactions
1,913
Medicare Patients
816
Medicare Billing
$59,468
Payment Breakdown by Category
Other$539,611 (67.6%)
Consulting$163,131 (20.4%)
Travel$54,068 (6.8%)
Food & Beverage$41,033 (5.1%)
Education$295.93 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $532,811 | 228 | 66.8% |
| Consulting Fee | $163,131 | 82 | 20.4% |
| Travel and Lodging | $54,068 | 246 | 6.8% |
| Food and Beverage | $41,033 | 1,338 | 5.1% |
| Honoraria | $3,800 | 3 | 0.5% |
| Grant | $3,000 | 1 | 0.4% |
| Education | $295.93 | 15 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $396,914 | 543 | $0 (2024) |
| GENZYME CORPORATION | $157,552 | 206 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $81,139 | 172 | $0 (2024) |
| ABBVIE INC. | $42,181 | 69 | $0 (2024) |
| Dermavant Sciences, Inc. | $31,530 | 33 | $0 (2024) |
| Genentech USA, Inc. | $30,130 | 54 | $0 (2024) |
| Amgen Inc. | $12,183 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $8,152 | 162 | $0 (2024) |
| Genentech, Inc. | $7,200 | 11 | $0 (2023) |
| Mylan Specialty L.P. | $5,525 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $223,891 | 329 | AstraZeneca Pharmaceuticals LP ($74,271) |
| 2023 | $190,880 | 360 | AstraZeneca Pharmaceuticals LP ($94,988) |
| 2022 | $170,349 | 371 | AstraZeneca Pharmaceuticals LP ($109,543) |
| 2021 | $113,064 | 267 | AstraZeneca Pharmaceuticals LP ($77,282) |
| 2020 | $30,334 | 119 | AstraZeneca Pharmaceuticals LP ($17,550) |
| 2019 | $32,071 | 168 | AstraZeneca Pharmaceuticals LP ($16,466) |
| 2018 | $30,305 | 165 | GENZYME CORPORATION ($9,558) |
| 2017 | $7,244 | 134 | Mylan Specialty L.P. ($5,478) |
All Payment Transactions
1,913 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $7,462.00 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $31.79 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/12/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Immunology | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Dermatology | ||||||
| 11/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $28.14 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $129.03 | General |
| 11/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| 11/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Consulting Fee | Cash or cash equivalent | $5,830.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | In-kind items and services | $544.99 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 163 | 273 | $35,865 | $13,117 |
| 2022 | 6 | 206 | 593 | $46,830 | $15,986 |
| 2021 | 9 | 259 | 654 | $53,430 | $18,218 |
| 2020 | 7 | 188 | 434 | $40,510 | $12,147 |
Total Patients
816
Total Services
1,954
Medicare Billing
$59,468
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 80 | $14,400 | $6,629 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $9,425 | $3,299 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $4,900 | $2,038 | 41.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 17 | 107 | $4,280 | $754.91 | 17.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 22 | 22 | $2,860 | $397.00 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 71 | $12,780 | $5,885 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $11,700 | $4,255 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 61 | $8,540 | $3,850 | 45.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 16 | 299 | $5,980 | $794.01 | 13.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 15 | 95 | $3,800 | $676.85 | 17.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 29 | 31 | $4,030 | $524.53 | 13.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $13,650 | $4,977 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 55 | $9,900 | $4,722 | 47.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 82 | $11,480 | $4,628 | 40.3% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 20 | 327 | $6,540 | $1,025 | 15.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,640 | $936.10 | 35.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 18 | $1,800 | $694.55 | 38.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 28 | 30 | $3,900 | $598.78 | 15.4% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 16 | 77 | $3,080 | $480.81 | 15.6% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 11 | 11 | $440.00 | $154.76 | 35.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $13,000 | $4,481 | 34.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 53 | $9,540 | $3,367 | 35.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 53 | $7,420 | $2,479 | 33.4% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 17 | 94 | $3,760 | $556.02 | 14.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 13 | 164 | $3,280 | $521.61 | 15.9% |
About Dr. Justin Greiwe, M.D
Dr. Justin Greiwe, M.D is a Allergy & Immunology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1942444807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Greiwe, M.D has received a total of $798,138 in payments from pharmaceutical and medical device companies, with $223,891 received in 2024. These payments were reported across 1,913 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($532,811).
As a Medicare-enrolled provider, Greiwe has provided services to 816 Medicare beneficiaries, totaling 1,954 services with total Medicare billing of $59,468. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Cincinnati, OH
- Active Since 04/22/2009
- Last Updated 07/26/2022
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1942444807
Products in Payments
- FASENRA (Biological) $200,825
- DUPIXENT (Biological) $197,580
- AIRSUPRA (Drug) $67,382
- TEZSPIRE (Biological) $65,073
- FASENRA (Drug) $38,702
- RINVOQ (Biological) $38,654
- Xolair (Biological) $37,207
- TAPINAROF (Drug) $19,572
- DUPIXENT (Drug) $14,228
- VTAMA (Drug) $11,957
- DUPIXENT DUPILUMAB INJECTION (Biological) $8,779
- NUCALA (Biological) $5,998
- Dymista (Drug) $5,478
- OPZELURA (Drug) $5,190
- SKYRIZI (Biological) $1,465
- Haegarda (Biological) $1,110
- PALFORZIA (Biological) $1,051
- CUVITRU (Biological) $829.29
- SKYRIZI (Drug) $576.98
- ALVESCO (Drug) $569.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Cincinnati
Marc Rothenberg, M.d, M.D
Allergy & Immunology — Payments: $239,073
Allergy & Immunology $239,073
Gordon Myers, M.d, M.D
Allergy & Immunology — Payments: $222,669
Allergy & Immunology $222,669
Dr. Sheharyar Durrani, Md, MD
Allergy & Immunology — Payments: $89,979
Allergy & Immunology $89,979
Jeffrey Raub, Md, MD
Allergy & Immunology — Payments: $10,620
Allergy & Immunology $10,620
Ann Ghory, M.d, M.D
Allergy & Immunology — Payments: $7,330
Allergy & Immunology $7,330
Dr. John Seyerle, Md, MD
Allergy & Immunology — Payments: $6,747
Allergy & Immunology $6,747